Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
A beta (Aβ or β-amyloid) is a key molecule in Alzheimer's disease (AD) pathogenesis. According to the ‘amyloid hypothesis’, the gradual accumulation of Aβ triggers events which results in neuronal loss in regions of the brain involved with memory and learning. Diverse agents have been developed...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Future Medicine
2014
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/44496 |